Abstract:Background: The basket trial evaluates the treatment effect of a targeted therapy in patients with the same genetic or molecular aberration, regardless of their cancer types. Bayesian hierarchical modeling has been proposed to adaptively borrow information across cancer types to improve the statistical power of basket trials. Although conceptually attractive, research has shown that Bayesian hierarchical models cannot appropriately determine the degree of information borrowing and may lead to substantially inflated type I error rates. Methods: We propose a novel calibrated Bayesian hierarchical model approach to evaluate the treatment effect in basket trials. In our approach, the shrinkage parameter that controls information borrowing is not regarded as an unknown parameter. Instead, it is defined as a function of a similarity measure of the treatment effect across tumor subgroups. The key is that the function is calibrated using simulation such that information is strongly borrowed across subgroups if their treatment effects are similar and barely borrowed if the treatment effects are heterogeneous. Results: The simulation study shows that our method has substantially better controlled type I error rates than the Bayesian hierarchical model. In some scenarios, for example, when the true response rate is between the null and alternative, the type I error rate of the proposed method can be inflated from 10% up to 20%, but is still better than that of the Bayesian hierarchical model. Limitation: The proposed design assumes a binary endpoint. Extension of the proposed design to ordinal and time-to-event endpoints is worthy of further investigation. Conclusion: The calibrated Bayesian hierarchical model provides a practical approach to design basket trials with more flexibility and better controlled type I error rates than the Bayesian hierarchical model. The software for implementing the proposed design is available at http://odin.mdacc.tmc.edu/~yyuan/index_code.html

rBMA: A robust Bayesian Model Averaging Method for phase II basket trials based on informative mixture priors

Mixture of Finite Mixtures Model for Basket Trial

BLAST: Bayesian Latent Subgroup Design for Basket Trials Accounting for Patient Heterogeneity

A Phase I-II Basket Trial Design to Optimize Dose-Schedule Regimes Based on Delayed Outcomes.

Phase I Trial Design for Drug Combinations with Bayesian Model Averaging.

Optimal Bayesian Hierarchical Model to Accelerate the Development of Tissue-Agnostic Drugs and Basket Trials.

A Bayesian Basket Trial Design Using Local Power Prior

A generalized calibrated Bayesian hierarchical modeling approach to basket trials with multiple endpoints

A Bayesian Platform Trial Design to Simultaneously Evaluate Multiple Drugs in Multiple Indications with Mixed Endpoints.

A win ratio-based framework to combine multiple clinical endpoints in exploratory basket trials

Bayesian Methods for Information Borrowing in Basket Trials: An Overview

Augmented Binary Method for Basket Trials (ABBA)

A Bayesian Basket Trial Design Using a Calibrated Bayesian Hierarchical Model

Frequentist analysis of basket trials with one-sample Mantel-Haenszel procedures

A Bayesian phase I/II platform design for co-developing drug combination therapies for multiple indications

New clinical trial design borrowing information across patient subgroups based on fusion-penalized regression models

Systematic comparison of Bayesian basket trial designs with unequal sample sizes and proposal of a new method based on power priors

Bayesian Phase II Adaptive Randomization by Jointly Modeling Time-to-event Efficacy and Binary Toxicity

BAYESIAN HIERARCHICAL RANDOM-EFFECTS META-ANALYSIS AND DESIGN OF PHASE I CLINICAL TRIALS

A Nonparametric Bayesian Basket Trial Design

A Bayesian Group Sequential Design for Randomized Biosimilar Clinical Trials with Adaptive Information Borrowing from Historical Data